Thank you.
On the medical isotope situation, when we experienced it the last time, provinces and territories put in contingency measures that they agreed to implement in the case of a shortage of medical isotopes. We need to put that out there, because when we were dealing with the shortage, each jurisdiction was responsible for rolling out contingency measures to mitigate the shortage of medical isotopes and the supply chain of that particular product. So provinces and territories and I have had this discussion.
I'll show you a letter I received from Nova Scotia saying they didn't incur any additional costs, so they were not going to ask for additional money because they had implemented their contingency measures. Nova Scotia is the jurisdiction where we have the highest cancer rates in this country.
So if you want to put forward what you incurred I will be happy to review that information in the context of how you implemented the contingency measures we agreed on to mitigate the shortage of supplies. I'm still open to that. I have not received a formal request from any jurisdiction, and some jurisdictions have come forward to say they did not incur any costs so they're not coming forward with additional requests.
Thank you.